A leading integrated LatAm healthcare and pharmaceutical conglomerate.
Share: email Subscribe
Weekly Top Stories Tue, 03 Jan 2023
We have 30 articles this week. #ABM Respiratory Care Announces the FDA Clearance of the #BiWaze Clear System. #Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office. #Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).#Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults. #FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor)#MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults. #TransCode Therapeutics Announces FDA Authorization to Proceed with First-In-Human Clinical Trial.
Editor's Choice
1. 
 Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
2. 
 Why the Future of Lateral Flow Testing is Digital
3. 
 CEL-SCI Reports Fiscal 2022 Financial Results and Clinical & Corporate Developments
4. 
 Heal Plans Layoffs Ahead of the Potential Sale and More Digital Health Briefs
5. 
 Digital Health Leaders Predict More Stabilized Funding in 2023
Top 10 M&A Transactions
6. 
 ABM Respiratory Care Announces the FDA Clearance of the BiWaze Clear System
7. 
 Alterity Therapeutics Announces Allowance of New Composition of Matter Patent By the United States Patent and Trademark Office
8. 
 Sientra Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9. 
 Vericel Announces FDA Approval of Nexobrid for the Treatment of Severe Thermal Burns in Adults
10. 
 FDA Grants Appeal for Ardelyx’s XPHOZAH® (tenapanor)
11. 
 MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
12. 
 TransCode Therapeutics Announces FDA Authorization to Proceed with First-in-Human Clinical Trial
13. 
 AWS Launches Amazon Omics for Precision Medicine
14. 
 Tempus Launches Real-World Data-Driven Program to Accelerate Precision Oncology Research
15. 
 Real-World Study Uses AI to Identify Undiagnosed Dementia in Primary Care
Top 4 Venture Funding
16. 
 Skanska Expands Hospital in San Antonio, Texas, USA, for USD 95M, About SEK 960m
17. 
 Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2027 and $74.75 Million Public Offering of Common Stock
18. 
 TRACON Pharmaceuticals Announces up to $30m Non-recourse Non-Dilutive Financing Related to Arbitration Award Decision Expected in Q1 2023
19. 
 AcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock
Top 4 Partnerships Announcements
20. 
 ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement
21. 
 Retractable Technologies, Inc. Reports Private Stock Repurchase
22. 
 Catalyst Biosciences Completes First Steps in Reverse Merger Plan
23. 
 Minerva Surgical Announces $30 Million Private Placement of Common Stock Led By Accelmed Partners
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us